Accord Healthcare receives positive CHMP opinion for IMULDOSA®, ustekinumab biosimilar to Stelara®

Oct 19, 2024

Ahmedabad (Gujarat) [India], October 19: Accord Healthcare Limited (Accord) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

European Medicine Agency accepts Intas' Marketing Authorization Application for DMB-3115, a Proposed Biosimilar to Stelara (Ustekinumab)

Jul 14, 2023

Ahmedabad (Gujarat) [India], July 14: Intas Pharmaceuticals Ltd. announced that the European Medicine Agency (EMA) confirms acceptance of the Marketing Authorization Application (MAA) for...

DMB Unveils a Delectable Transformation of Kaju Katli (first of its kind) at WMNC 2023, Kolkata

Dec 22, 2023

Jaipur (Rajasthan) [India], December 22: Jaipur-based Doodh Misthan Bhandar (now DMB Sweets) marked a significant chapter in its culinary journey at the WMNC 2023...